IL17A and psoriasis: The IL17A vaccine successfully inhibited the symptoms of proteolipid protein peptide 139–151-induced EAE in Swiss Jim Lambert (SJL) mice.32 IL17A peptide-based vaccine has also been used to treat psoriasis.